ATE407665T1 - Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken - Google Patents

Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken

Info

Publication number
ATE407665T1
ATE407665T1 AT03747680T AT03747680T ATE407665T1 AT E407665 T1 ATE407665 T1 AT E407665T1 AT 03747680 T AT03747680 T AT 03747680T AT 03747680 T AT03747680 T AT 03747680T AT E407665 T1 ATE407665 T1 AT E407665T1
Authority
AT
Austria
Prior art keywords
shell
release
dosage form
core
diffusion
Prior art date
Application number
AT03747680T
Other languages
English (en)
Inventor
Chen-Chao Wang
Jaedeok Yoo
Esteban Bornancini
Willie Roach
Monica Motwani
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE407665T1 publication Critical patent/ATE407665T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10Processes of additive manufacturing
    • B29C64/141Processes of additive manufacturing using only solid materials
    • B29C64/153Processes of additive manufacturing using only solid materials using layers of powder being selectively joined, e.g. by selective laser sintering or melting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00Products made by additive manufacturing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03747680T 2002-05-06 2003-05-06 Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken ATE407665T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37844902P 2002-05-06 2002-05-06
US42509402P 2002-11-08 2002-11-08

Publications (1)

Publication Number Publication Date
ATE407665T1 true ATE407665T1 (de) 2008-09-15

Family

ID=29406838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03747680T ATE407665T1 (de) 2002-05-06 2003-05-06 Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken

Country Status (9)

Country Link
US (2) US8088415B2 (de)
EP (1) EP1503741B1 (de)
JP (1) JP5041663B2 (de)
AT (1) ATE407665T1 (de)
AU (1) AU2003232078A1 (de)
CA (1) CA2483028C (de)
DE (1) DE60323482D1 (de)
ES (1) ES2316791T3 (de)
WO (1) WO2003092633A2 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE407665T1 (de) 2002-05-06 2008-09-15 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
ATE544447T1 (de) * 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
JPWO2006004069A1 (ja) * 2004-07-01 2008-04-24 日本碍子株式会社 微小カプセルおよびその製造方法
EP2131817A2 (de) * 2007-03-09 2009-12-16 Synthon B.V. Pharmazeutische zusammensetzung von quetiapinfumarat
EP2227226B1 (de) * 2007-12-21 2016-10-26 Johnson & Johnson Consumer Inc. Herstellung einer tablette
CN101716162B (zh) * 2009-11-26 2012-11-14 扬州中宝制药有限公司 一种氨茶碱缓释胶囊及其制备方法
US8251837B2 (en) * 2010-08-11 2012-08-28 Nike, Inc. Floating golf ball
EP2651399A2 (de) 2010-12-13 2013-10-23 Purdue Pharma LP Retard-darreichungsformen
US9381154B2 (en) * 2011-06-09 2016-07-05 Xerox Corporation Direct inkjet fabrication of drug delivery devices
KR101835288B1 (ko) 2012-09-05 2018-03-06 아프레시아 파마슈티칼스 컴퍼니 3차원 인쇄 시스템 및 장비 어셈블리
US8888480B2 (en) 2012-09-05 2014-11-18 Aprecia Pharmaceuticals Company Three-dimensional printing system and equipment assembly
US20140099351A1 (en) * 2012-10-04 2014-04-10 Axxia Pharmaceuticals, Llc Process for making controlled release medical implant products
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
CN109908355B (zh) 2013-03-15 2022-11-15 阿普雷奇亚制药有限责任公司 包含左乙拉西坦的快速分散剂型
CN105579161A (zh) 2013-08-16 2016-05-11 艾克斯温有限责任公司 三维打印的金属铸造模具和其制造方法
EP3057729A4 (de) 2013-10-17 2017-10-18 The Exone Company Isostatische heisspressbehälter mit 3d-druck und verfahren zur herstellung davon
EP2875933B1 (de) * 2013-11-25 2019-04-03 MTU Aero Engines GmbH Dokumentation generativer Herstellungsverfahren
US9649279B2 (en) 2013-12-16 2017-05-16 Massachusetts Institute Of Technology Fortified micronutrient salt formulations
EP3763383A1 (de) * 2013-12-16 2021-01-13 Massachusetts Institute Of Technology Mikrogeformte oder 3d-gedruckte impfstoffformulierungen mit pulsierender freisetzung
ES2745763T3 (es) 2013-12-23 2020-03-03 The Exone Co Métodos y sistemas para la impresión en tres dimensiones utilizando múltiples fluidos aglutinantes
EP3086922B1 (de) 2013-12-23 2022-03-09 The Exone Company Verfahren zum dreidimensionalen drucken unter verwendung eines mehrkomponentigen konstruktionspulvers
IL232696B (en) * 2014-05-19 2018-08-30 Technion Res & Dev Foundation Compound and method for detecting molecules of interest
EP3148730A1 (de) 2014-05-29 2017-04-05 The Exone Company Verfahren zur herstellung von superlegierungsartikeln auf nickelbasis durch dreidimensionales drucken
WO2016011098A2 (en) 2014-07-17 2016-01-21 The Exone Company Methods and apparatuses for curing three-dimensional printed articles
CN114670437A (zh) * 2014-09-08 2022-06-28 中央兰开夏大学 固体剂型生产
US9844930B2 (en) 2014-11-05 2017-12-19 Xerox Corporation 3D printing of digestible shells for medicaments
CN107206746A (zh) 2014-12-03 2017-09-26 艾克斯温有限责任公司 通过三维打印制造致密碳制品的方法
CN108721242B (zh) * 2015-06-03 2021-03-02 南京三迭纪医药科技有限公司 药品剂型及其使用
KR20180014778A (ko) 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
US20180214383A1 (en) * 2015-07-16 2018-08-02 National University Of Singapore Printing drug tablets with fully customizable release profiles for personalized medicine
CN116423825A (zh) 2015-08-21 2023-07-14 阿普雷奇亚制药有限责任公司 三维打印系统和设备组件
GB201519128D0 (en) 2015-10-29 2015-12-16 Univ Central Lancashire Solid forms and methods of preparing the same
CA3023278C (en) 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
GB201612853D0 (en) 2016-07-25 2016-09-07 Univ Central Lancashire Solid dosage form production
EP3321002A1 (de) * 2016-11-15 2018-05-16 Höganäs AB Ausgangsmaterial für generatives fertigungsverfahren, generatives fertigungsverfahren damit und daraus erhaltener artikel
DE102017200773A1 (de) * 2017-01-18 2018-07-19 Eos Gmbh Electro Optical Systems Verfahren zum Nachbehandeln und Nachbehandlungssytem
KR20230157528A (ko) * 2017-01-26 2023-11-16 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
US10369557B2 (en) 2017-04-12 2019-08-06 International Business Machines Corporation Three-dimensional printed objects for chemical reaction control
US20210213678A1 (en) * 2017-04-28 2021-07-15 Hewlett-Packard Development Company, L.P. Producing diffusion-controlled release devices
WO2019025869A1 (en) * 2017-07-31 2019-02-07 Teva Pharmaceutical Industries Limited GALENIC FORMS WITH CONTROLLED RELEASE MANUFACTURED IN ADDITIVE MANNER
US11642841B2 (en) 2017-10-13 2023-05-09 Ut-Battelle, Llc Indirect additive manufacturing process
WO2019137200A1 (en) 2018-01-09 2019-07-18 Triastek, Inc. Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant
US10350822B1 (en) 2018-01-09 2019-07-16 Triastek Inc. Dosage forms with desired release profiles and methods of designing and making thereof
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
DE102018107585B3 (de) * 2018-03-29 2019-03-28 Universität Rostock Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
WO2019199328A1 (en) * 2018-04-13 2019-10-17 Hewlett-Packard Development Company, L.P. Three-dimensional printing
CN108939162B (zh) * 2018-07-10 2021-11-19 上海理工大学 一种介孔生物玻璃/海藻酸钠-海藻酸钠分层骨组织工程支架的制备方法
GB201813186D0 (en) 2018-08-13 2018-09-26 Univ Central Lancashire Solid dosage from production
WO2020053319A1 (en) * 2018-09-14 2020-03-19 Merck Patent Gmbh Process for the preparation of a coated solid pharmaceutical dosage form
ES2930199T3 (es) 2018-10-15 2022-12-07 Aprecia Pharmaceuticals LLC Método y sistema para formar una forma farmacéutica dentro de un envase
US11254617B2 (en) 2019-01-09 2022-02-22 Ut-Battelle, Llc Indirect additive manufacturing process using amine-containing adhesive polymers
US12103229B2 (en) * 2019-03-15 2024-10-01 Ricoh Company, Ltd. Jettable temporary binders to create removable support materials
US11724486B2 (en) 2019-07-09 2023-08-15 Kyndryl, Inc. Printing customized medication based on current user data and medical records of the user
AU2020329531A1 (en) * 2019-08-14 2022-03-31 Merck Patent Gmbh Method for additive manufacture of a product, manufacturing device and solid pharmaceutical dosage form
GB201913972D0 (en) 2019-09-27 2019-11-13 Univ Ulster Pharmaceutical Delivery Device and method of manufacture
ES2828509B2 (es) 2019-11-26 2022-03-09 Fund Idonial Composicion para la impresion 3d de farmacos semisolidos
EP3871859A1 (de) * 2020-02-26 2021-09-01 Hewlett-Packard Development Company, L.P. Dreidimensionales drucken
WO2021176361A1 (en) * 2020-03-02 2021-09-10 Craft Health Pte Ltd Method of manufacturing oral dosage forms for extended drug release
CN116018131A (zh) 2020-06-26 2023-04-25 阿普雷奇亚制药有限责任公司 具有内腔的快速口腔分散片剂
EP4238556A4 (de) 2020-10-30 2024-09-25 Triastek Inc Gastroretentive pharmazeutische darreichungsform
CN112940690B (zh) * 2021-02-05 2021-11-02 中国科学院苏州纳米技术与纳米仿生研究所南昌研究院 一种具有豆荚结构的相变储能材料及其制备方法与应用
WO2024108084A1 (en) * 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Functionally-dividable orodispersive dosage form

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US948297A (en) * 1909-07-24 1910-02-01 John A Stone Corn-husker.
US986148A (en) * 1910-05-09 1911-03-07 Hoechst Ag Derivative of oxyarylarsinic acids and process of making same.
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5204055A (en) 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
NZ286242A (en) * 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
US5490882A (en) 1992-11-30 1996-02-13 Massachusetts Institute Of Technology Process for removing loose powder particles from interior passages of a body
US5775402A (en) 1995-10-31 1998-07-07 Massachusetts Institute Of Technology Enhancement of thermal properties of tooling made by solid free form fabrication techniques
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US6280771B1 (en) 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
ATE292456T1 (de) * 1996-09-13 2005-04-15 Shionogi & Co Zubereitung mit verlängerter freisetzung unter verwendung einer thermischen umwandlung sowie verfahren zu deren herstellung
WO1998036738A1 (en) 1997-02-20 1998-08-27 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
US5934343A (en) 1997-03-31 1999-08-10 Therics, Inc Method for dispensing of powders
US6213168B1 (en) 1997-03-31 2001-04-10 Therics, Inc. Apparatus and method for dispensing of powders
US6547994B1 (en) 1998-11-13 2003-04-15 Therics, Inc. Rapid prototyping and manufacturing process
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
WO2001087272A2 (en) * 2000-05-18 2001-11-22 Therics, Inc. Encapsulating a toxic core within a non-toxic region in an oral dosage form
WO2002038280A2 (en) * 2000-11-10 2002-05-16 Therics, Inc. A wetting-resistant nozzle for dispensing small volumes of liquid and a method for manufacturing a wetting-resistant nozzle
ATE407665T1 (de) 2002-05-06 2008-09-15 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
US20050015728A1 (en) * 2003-07-17 2005-01-20 International Business Machines Corporation Method, system, and program product for customizing a user interface

Also Published As

Publication number Publication date
CA2483028A1 (en) 2003-11-13
DE60323482D1 (de) 2008-10-23
EP1503741B1 (de) 2008-09-10
WO2003092633A2 (en) 2003-11-13
US8465777B2 (en) 2013-06-18
EP1503741A2 (de) 2005-02-09
JP2005524702A (ja) 2005-08-18
US8088415B2 (en) 2012-01-03
ES2316791T3 (es) 2009-04-16
CA2483028C (en) 2011-04-05
US20120177696A1 (en) 2012-07-12
US20040005360A1 (en) 2004-01-08
WO2003092633A3 (en) 2004-04-08
AU2003232078A1 (en) 2003-11-17
JP5041663B2 (ja) 2012-10-03

Similar Documents

Publication Publication Date Title
ATE407665T1 (de) Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
BRPI0912411B8 (pt) uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune
MX348282B (es) Formulaciones farmaceuticas de liberacion controlada de nitazoxanida.
WO2003084539A3 (en) New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
MY149601A (en) Masking the taste of powders
EP1523994A4 (de) Medizinische zusammensetzung zur regulierung der freisetzung und verfahren zu deren herstellung
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
PL367277A1 (en) Methods of making sustained release formulations of oxymorphone related applications
WO2005115530A3 (en) Seizure therapy method and apparatus
HUP0400782A2 (hu) Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények
IL192374A0 (en) Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
MX2008011978A (es) Tratamiento del cancer de seno negativo al triple receptor.
DE502004005154D1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein-wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
TW200738228A (en) Neramexane modified release matrix tablet
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
NO20071044L (no) Doseformer med enteraltbelagte tablettkjerner
EP3981399A4 (de) Orale feste tablette mit einem tyrosinkinaseinhibitor und herstellungsverfahren dafür
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
WO2021034958A3 (en) Materials for delivery of tetherable proteins in bone implants
UA91694C2 (ru) Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций
MX2007005525A (es) Tratamiento terapeutico de resorcion ose acelerada.
WO2009024838A3 (en) Impression and model components
TW200621312A (en) Oral solid dosage forms containing a low dose of estradiol
RS20050835A (en) Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
ECSP045232A (es) Forma de dosificación oral, procedimiento para prepararla y uso de una base débil farmacéuticamente aceptable o una sal o solvato farmacéuticamente aceptable de la misma para preparar dicha forma de dosificación oral

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties